PAM
BEAT

Premier Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Premier Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,170
Closed -$237K – 126
2017
Q3 		$237K Buy
+7,170
New +$248K 0.05% 107

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Premier Asset Management's BEAT Position: Q4 2017 in Review

Premier Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 7,170 shares — an estimated $237K sold.

Premier Asset Management first reported a position in BEAT in Q3 2017 and held it in 1 quarter. The position peaked at $237K in Q3 2017. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

  • Premier Asset Management reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
  • Premier Asset Management sold 7,170 BioTelemetry, Inc. shares in Q4 2017, an estimated $237K.
  • Premier Asset Management first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 1 quarter.
  • Premier Asset Management's BioTelemetry, Inc. position peaked at $237K in Q3 2017.
  • 192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on Premier Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.